InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the full record of transactions filed by Paterson Dan, Co-Président. Director active across 1 company, notably Verastem, Inc.. In total, 9 disclosures have been published. Split: 0 buy · 6 sells. Total volume traded: €135k. History available since 12 August 2021. The latest transaction was disclosed on 21 June 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
2,701 shares@ US$1.140.0005% mcap0.8% of flowCommon StockSEC:0001104659-22-073486:0
15,000 shares0Common StockSEC:0001104659-22-061939:0
2,818 shares@ US$1.270.0005% mcap0.9% of flowCommon StockSEC:0001104659-22-037009:0
23,534 shares@ US$2.050.0071% mcap11.1% of flowCommon StockSEC:0001104659-22-001447:0
23,534 shares@ US$2.050.0071% mcap22.6% of flowCommon StockSEC:0001104659-22-001447
10,994 shares@ US$2.270.0037% mcap11.8% of flowCommon StockSEC:0001104659-21-152597
10,994 shares@ US$2.270.0037% mcap5.8% of flowCommon StockSEC:0001104659-21-152597:0
50,244 shares@ US$2.870.020% mcap65.5% of flowCommon StockSEC:0001104659-21-151116
50,244 shares@ US$2.870.020% mcap32.2% of flowCommon StockSEC:0001104659-21-151116:0
9 of 9 declarations
About Paterson Dan
Dan Paterson is the President and COO of Verastem, Inc., a biopharmaceutical company. He is responsible for the strategic direction and operations of the company. His expertise in the biopharmaceutical sector allows him to lead initiatives aimed at developing new treatments and improving patient outcomes.
